295 related articles for article (PubMed ID: 24496074)
1. Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease.
Bedse G; Romano A; Cianci S; Lavecchia AM; Lorenzo P; Elphick MR; Laferla FM; Vendemiale G; Grillo C; Altieri F; Cassano T; Gaetani S
J Alzheimers Dis; 2014; 40(3):701-12. PubMed ID: 24496074
[TBL] [Abstract][Full Text] [Related]
2. Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's disease.
Lebbadi M; Julien C; Phivilay A; Tremblay C; Emond V; Kang JX; Calon F
J Alzheimers Dis; 2011; 27(4):853-69. PubMed ID: 21914946
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB
Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent increment of hydroxymethylation in the brain cortex in the triple-transgenic mouse model of Alzheimer's disease.
Cadena-del-Castillo C; Valdes-Quezada C; Carmona-Aldana F; Arias C; Bermúdez-Rattoni F; Recillas-Targa F
J Alzheimers Dis; 2014; 41(3):845-54. PubMed ID: 24685633
[TBL] [Abstract][Full Text] [Related]
5. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC
J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer's Disease.
Llorente-Ovejero A; Manuel I; Lombardero L; Giralt MT; Ledent C; Giménez-Llort L; Rodríguez-Puertas R
J Alzheimers Dis; 2018; 64(1):117-136. PubMed ID: 29865071
[TBL] [Abstract][Full Text] [Related]
8. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of serum proteins in triple transgenic Alzheimer's disease mice: implications for identifying biomarkers for use to screen potential candidate therapeutic drugs for early Alzheimer's disease.
Sui X; Ren X; Huang P; Li S; Ma Q; Ying M; Ni J; Liu J; Yang X
J Alzheimers Dis; 2014; 40(3):575-86. PubMed ID: 24496070
[TBL] [Abstract][Full Text] [Related]
10. Decreased hippocampal cell proliferation correlates with increased expression of BMP4 in the APPswe/PS1DeltaE9 mouse model of Alzheimer's disease.
Li D; Tang J; Xu H; Fan X; Bai Y; Yang L
Hippocampus; 2008; 18(7):692-8. PubMed ID: 18398851
[TBL] [Abstract][Full Text] [Related]
11. Age-dependent phenotypic characteristics of a triple transgenic mouse model of Alzheimer disease.
Pietropaolo S; Feldon J; Yee BK
Behav Neurosci; 2008 Aug; 122(4):733-47. PubMed ID: 18729626
[TBL] [Abstract][Full Text] [Related]
12. Impaired Src signaling and post-synaptic actin polymerization in Alzheimer's disease mice hippocampus--linking NMDA receptors and the reelin pathway.
Mota SI; Ferreira IL; Valero J; Ferreiro E; Carvalho AL; Oliveira CR; Rego AC
Exp Neurol; 2014 Nov; 261():698-709. PubMed ID: 25128699
[TBL] [Abstract][Full Text] [Related]
13. REST/NRSF-induced changes of ChAT protein expression in the neocortex and hippocampus of the 3xTg-AD mouse model for Alzheimer's disease.
Orta-Salazar E; Aguilar-Vázquez A; Martínez-Coria H; Luquín-De Anda S; Rivera-Cervantes M; Beas-Zarate C; Feria-Velasco A; Díaz-Cintra S
Life Sci; 2014 Oct; 116(2):83-9. PubMed ID: 25261598
[TBL] [Abstract][Full Text] [Related]
14. Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex.
Lee JH; Agacinski G; Williams JH; Wilcock GK; Esiri MM; Francis PT; Wong PT; Chen CP; Lai MK
Neurochem Int; 2010 Dec; 57(8):985-9. PubMed ID: 21034788
[TBL] [Abstract][Full Text] [Related]
15. Evidence for altered Numb isoform levels in Alzheimer's disease patients and a triple transgenic mouse model.
Chigurupati S; Madan M; Okun E; Wei Z; Pattisapu JV; Mughal MR; Mattson MP; Chan SL
J Alzheimers Dis; 2011; 24(2):349-61. PubMed ID: 21258150
[TBL] [Abstract][Full Text] [Related]
16. Targeting neurogenesis ameliorates danger assessment in a mouse model of Alzheimer's disease.
Shruster A; Offen D
Behav Brain Res; 2014 Mar; 261():193-201. PubMed ID: 24388979
[TBL] [Abstract][Full Text] [Related]
17. Amyloid and tau neuropathology differentially affect prefrontal synaptic plasticity and cognitive performance in mouse models of Alzheimer's disease.
Lo AC; Iscru E; Blum D; Tesseur I; Callaerts-Vegh Z; Buée L; De Strooper B; Balschun D; D'Hooge R
J Alzheimers Dis; 2013; 37(1):109-25. PubMed ID: 23788007
[TBL] [Abstract][Full Text] [Related]
18. Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease.
Do TM; Alata W; Dodacki A; Traversy MT; Chacun H; Pradier L; Scherrmann JM; Farinotti R; Calon F; Bourasset F
Neuropharmacology; 2014 Jun; 81():311-7. PubMed ID: 24631967
[TBL] [Abstract][Full Text] [Related]
19. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease.
Imbimbo BP; Giardino L; Sivilia S; Giuliani A; Gusciglio M; Pietrini V; Del Giudice E; D'Arrigo A; Leon A; Villetti G; Calzà L
J Alzheimers Dis; 2010; 20(1):159-73. PubMed ID: 20164581
[TBL] [Abstract][Full Text] [Related]
20. Functional autoradiography shows unaltered cannabinoid CB1 receptor signalling in hippocampus and cortex of APP/PS1 transgenic mice.
Kärkkäine E; Tanila H; Laitinen JT
CNS Neurol Disord Drug Targets; 2012 Dec; 11(8):1038-44. PubMed ID: 23244427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
